Shares Magazine
Jump to:
Tristel Fundamentals
| Company Name | Tristel | Last Updated | 04 Jun 2020 |
|---|---|---|---|
| Industry | Health Care | Sector | Health Care Providers |
| Shares in Issue (m) | 45.28 | Market Cap (£m) | 215.07 |
| PE Ratio | 51.97 | Div per Share (p) | 5.54 |
| Div Yield | 1.23 | Div Cover | 1.57 |
| EPS | 9.14 | EPS Growth (%) | 19.95 |
| PEG | 2.61 | DPS Growth (%) | 20.96 |
| Debt Ratio | 3.14 | Debt Equity Ratio | 0.15 |
| Net Gearing | 3.38 | Gross Gearing | 18.02 |
| Asset Equity Ratio | 1.22 | Cash Equity Ratio | 17.85 |
| Quick Ratio | 2.18 | Current Ratio | 2.86 |
| Price To Book Value | 9.21 | ROCE | 19.70 |
Tristel Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| H1 Dividend | 26 Mar 2020 | 30 Apr 2020 | GBX | 2.34 | |
| H2 Dividend | 21 Nov 2019 | 20 Dec 2019 | GBX | 3.50 | 5.54 |
| H1 Dividend | 28 Mar 2019 | 30 Apr 2019 | GBX | 2.04 | |
| H2 Dividend | 15 Nov 2018 | 14 Dec 2018 | GBX | 2.98 | 4.58 |
| H1 Dividend | 22 Mar 2018 | 12 Apr 2018 | GBX | 1.60 | |
| H2 Dividend | 16 Nov 2017 | 15 Dec 2017 | GBX | 2.63 | 4.03 |
| H1 Dividend | 23 Mar 2017 | 13 Apr 2017 | GBX | 1.40 | |
| H2 Dividend | 17 Nov 2016 | 16 Dec 2016 | GBX | 2.19 | 3.33 |
| Special Dividend | 28 Jul 2016 | 05 Aug 2016 | GBX | 3.00 | |
| H1 Dividend | 17 Mar 2016 | 01 Apr 2016 | GBX | 1.14 | |
| H2 Dividend | 19 Nov 2015 | 18 Dec 2015 | GBX | 2.14 | 2.72 |
| Special Dividend | 25 Jun 2015 | 06 Aug 2015 | GBX | 3.00 |
Tristel Company Financials
| Assets (£m) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Tangible Assets | 1 | 1 | 1 |
| Intangible Assets | 13 | 7 | 7 |
| Investments | 2 | 1 | 1 |
| Total Fixed Assets | 16 | 9 | 9 |
| Stocks | 3 | 2 | 2 |
| Debtors | 5 | 4 | 4 |
| Cash & Equivalents | 4 | 7 | 5 |
| Other Assets | 0 | 0 | 0 |
| Total Assets | 28 | 23 | 20 |
| Liabilities (£m) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Creditors within 1 year | 4 | 4 | 4 |
| Creditors after 1 year | 1 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | 5 | 4 | 4 |
| Net assets | 23 | 18 | 16 |
| Equity (£m) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Called up share capital | 0 | 0 | 0 |
| Share Premium | 11 | 11 | 11 |
| Profit / Loss | 5 | 4 | 4 |
| Other Equity | 2 | 0 | 1 |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | 23 | 18 | 16 |
| Ratios | 2019 | 2018 | 2017 |
|---|---|---|---|
| Debt Ratio | 3.14 | 1.10 | 1.08 |
| Debt-to-Equity | 0.15 | 0.05 | 0.04 |
| Net Gearing | 3.38 | -11.30 | -5.16 |
| Gross Gearing | 18.02 | 18.25 | 20.14 |
| Assets / Equity | 1.22 | 1.22 | 1.25 |
| Cash / Equity | 17.85 | 36.15 | 31.68 |
| EPS | 9.14 | 7.62 | 8.06 |
| Cash Flow (£m) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Cash from operating activities | 5 | 5 | 4 |
| Cashflow before financing | -1 | 3 | 2 |
| Increase in Cash | -3 | 2 | -1 |
| Income (£m) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Turnover | 26 | 22 | 20 |
| Cost of sales | 6 | 5 | 5 |
| Gross Profit | 21 | 17 | 16 |
| Operating Profit | 5 | 4 | 4 |
| Pre-Tax profit | 5 | 4 | 4 |
| Profit / Loss for the year | 0 | 0 | 0 |
Tristel Company Background
| Sector | Health Care Providers |
|---|---|
| Activities | Tristel plc is a healthcare business specialising in infection control in hospitals. Tristel markets a proprietary chlorine dioxide chemistry that is highly effective in destroying all types of bacteria (including bacterial spores, tuberculosis and MRSA), fungi and viruses and is one of a small group of sporicidal agents that is safe and easy to use. Tristel's core product range of instrument disinfectants has become the market leader in the UK Acute & Private Hospital sector. They are used to decontaminate heat sensitive endoscopic and ultrasound instruments in over 375 hospitals, representing some 60 per cent. of all UK NHS Acute & Private Hospitals. |
| Latest Interim Date | 24 Feb 2020 |
| Latest Fiscal Year End Date | 16 Oct 2019 |
Tristel Directors
| Appointed | Director | Position |
|---|---|---|
| 24 May 2004 | Paul Christopher Swinney | Chief Executive Officer |
| 02 Jun 2010 | Elizabeth Amanda Dixon | Finance Director |
| 05 Feb 2019 | Dr Bruno Luc Myriam Holthof | Non-Executive Chairman |
| 01 Oct 2015 | David William Edmund Orr | Non-Executive Director |
| 06 Dec 2018 | Bart Leemans | Non-Executive Director |
| 19 Oct 2017 | Thomas Arthur John Jenkins | Non-Executive Director |
| 24 May 2004 | Paul Martin Barnes | Non-Executive Director |
| 27 Apr 2020 | Isabel Josephine Sutherland Napper | Non-Executive Director |
Tristel Contact Details
| Company Name | Tristel |
|---|---|
| Company Address | Lynx Business Park, Fordham Road, Snailwell, Cambridgeshire CB8 7NY. |
| Company Telephone | +44 (0)845 5214124 |
| Company Website | http://www.tristel.com/ |
Tristel Advisors
| Auditor Name | Grant Thornton UK LLP |
|---|---|
| Auditor Address | No 1 Whitehall Riverside, Leeds, West Yorkshire LS1 4BN. |
| Auditor Website | http://www.grant-thornton.co.uk/ |
| Auditor Telephone | +44 (0)113 245 5514 |
| Registrar Name | Computershare Investor Service |
| Registrar Address | The Pavillions, Bridgwater Road, Bristol BS99 1XZ. |
| Registrar Website | http://www-uk.computershare.com/ |
| Registrar Telephone | 0870 702 0010 |
| Broker Name | finnCap |
| Broker Address | 60 New Broad Street |
| Broker Website | http://www.finncap.com/ |
| Broker Telephone | +44 (0)207 220 0500 |
| Adviser Name | finnCap |
| Adviser Address | 60 New Broad Street |
| Adviser Website | http://www.finncap.com/ |
| Adviser Telephone | +44 (0)207 220 0500 |
| Solicitor Name | Maclay Murray & Spens LLP |
| Solicitor Address | 1 London Wall, London EC2Y 5EZ. |
| Solicitor Website | http://www.mms.co.uk/ |
| Solicitor Telephone | +44 (0)20 7002 8500 |
| Stockbroker Name | n/a |
| Stockbroker Address | n/a |
| Stockbroker Website | n/a |
| Stockbroker Telephone | n/a |
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
